Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul-Aug;41(4):528-536.
doi: 10.1016/j.clindermatol.2023.08.009. Epub 2023 Aug 15.

Rosacea: The eyes have it

Affiliations

Rosacea: The eyes have it

Snejina Vassileva et al. Clin Dermatol. 2023 Jul-Aug.

Abstract

Rosacea is a chronic inflammatory dermatosis typically affecting the facial skin but also the eyes. With its chronic course with fluctuating episodes of flashing, redness, papulopustules, and nodules it poses a severe psychologic burden to the affected individuals. In addition to the facial changes, more than half of the patients have ocular involvement ranging from blepharitis and conjunctival hyperemia to more severe ophthalmic damage, and even blindness. Clinically, the ocular involvement in rosacea includes meibomian gland dysfunction with relapsing hordeola and chalazia, diffuse hyperemic conjunctivitis, photophobia, episcleritis, or kerato-conjunctivitis, and in rare cases, corneal ulcers. These are mainly observed in adult patients but can also occur in children. Depending on the degree of cutaneous or ocular findings, patients with rosacea may present first to the dermatologist or to the ophthalmologist. Both specialists should be aware of the potential oculocutaneous involvement. Any ocular complaints expressed by the patient in the setting of a dermatologist's office should be referred promptly for an ophthalmologic examination. Conversely, signs suggestive of rosacea in the eye should lead the ophthalmologist to consider underlying skin disease. A timely interdisciplinary collaboration is paramount for the earlier diagnosis and treatment, thus preventing permanent eye impairment in this chronic dermatosis.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest Dr Vassileva received personal fees from AbbVie, Novartis, Johnson & Johnson, Eli Lilly, Sanofi, Roche, UCB, and Berlin Chemie, outside of the submitted work. Dr Drenovska personal fees from Roche, AbbVie, Johnson & Johnson, Novartis, and Eli Lilly, outside the submitted work. Dr Tanev has no conflicts of interest to declare.

LinkOut - more resources